Company intelligence / Profile preview

MicroCyto

Ownership: Private
Development stage: Commercial

Overview

MicroCyto is a Beijing-based biomanufacturing company founded in 2021 that uses synthetic biotechnology to produce various compounds for applications across medicine, daily chemicals, agriculture, food, feed, and materials. It has raised $28.8M to date and is active with ongoing operations[1][2][3]. No specific clinical results or therapeutic programs are reported.

Modalities: small molecules and biochemicals produced via synthetic biology
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on MicroCyto.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroCyto.

Explore the full profile